Research programme: monoclonal antibody therapeutics - Human monoclonal international/Morphotek
Latest Information Update: 25 May 2010
At a glance
- Originator Human Monoclonals International
- Developer Human Monoclonals International; Morphotek
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 11 Mar 2008 Preclinical trials in Cancer in USA (Parenteral)